{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:59:10Z","timestamp":1792083550373,"version":"4.4.0"},"reference-count":159,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2027,2]]},"DOI":"10.1016\/j.cca.2026.121285","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:02:23Z","timestamp":1787007743000},"page":"121285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Circular RNAs as diagnostic biomarkers and therapeutic regulators of metabolic reprogramming, immune escape and ferroptosis in hepatocellular carcinoma"],"prefix":"10.1016","volume":"593","author":[{"given":"Jinli","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Diao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaozhe","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoyang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haowei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.cca.2026.121285_bb0005","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","article-title":"Global burden of primary liver cancer in 2020 and predictions to 2040","volume":"77","author":"Rumgay","year":"2022","journal-title":"J. Hepatol."},{"issue":"8","key":"10.1016\/j.cca.2026.121285_bb0010","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.3390\/cancers16081582","article-title":"Hepatocellular carcinoma: current drug therapeutic status, advances and challenges","volume":"16","author":"Zheng","year":"2024","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.cca.2026.121285_bb0015","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.cca.2026.121285_bb0020","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s12094-025-04019-4","article-title":"Genetic landscape of cancer: mechanisms, key genes, and therapeutic implications","volume":"28","author":"Karnwal","year":"2026","journal-title":"Clin. Transl. Oncol."},{"issue":"2026","key":"10.1016\/j.cca.2026.121285_bb0025","article-title":"Functional interpretation of recurrent genetic variants in hepatocellular carcinoma: molecular consequences and clinical relevance","volume":"1","author":"Ye","year":"2026","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.cca.2026.121285_bb0030","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3389\/fendo.2018.00124","article-title":"The p53 tumor suppressor in the control of metabolism and ferroptosis","volume":"9","author":"Gnanapradeepan","year":"2018","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.cca.2026.121285_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1691297","article-title":"Role of the Wnt\/\u03b2-catenin signaling pathway in the development of HCC","volume":"16","author":"Lin","year":"2025","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.cca.2026.121285_bb0040","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.218","article-title":"Metabolic reprogramming in cancer: mechanisms and therapeutics","volume":"4","author":"Nong","year":"2023","journal-title":"MedComm"},{"issue":"1","key":"10.1016\/j.cca.2026.121285_bb0045","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12943-024-02119-3","article-title":"Altered metabolism in cancer: insights into energy pathways and therapeutic targets","volume":"23","author":"Tufail","year":"2024","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.cca.2026.121285_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.gendis.2025.101521","article-title":"Landscape of metabolic alterations and treatment strategies in breast cancer","volume":"12","author":"Wu","year":"2025","journal-title":"Genes & Diseases"},{"issue":"3","key":"10.1016\/j.cca.2026.121285_bb0055","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1039\/D1MO00022E","article-title":"Tissue metabolic profiling reveals major metabolic alteration in colorectal cancer","volume":"17","author":"Shen","year":"2021","journal-title":"Molecular omics"},{"issue":"2","key":"10.1016\/j.cca.2026.121285_bb0060","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/cas.15629","article-title":"Serum untargeted metabolomics reveal metabolic alteration of non-small cell lung cancer and refine disease detection","volume":"114","author":"Li","year":"2023","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.cca.2026.121285_bb0065","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/cancers12010002","article-title":"Metabolic alterations in pancreatic cancer progression","volume":"12","author":"Vernucci","year":"2019","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.cca.2026.121285_bb0070","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41581-023-00800-2","article-title":"Metabolic alterations in hereditary and sporadic renal cell carcinoma","volume":"20","author":"Coffey","year":"2024","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"10.1016\/j.cca.2026.121285_bb0075","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41421-023-00563-x","article-title":"Multi-dimensional single-cell characterization revealed suppressive immune microenvironment in AFP-positive hepatocellular carcinoma","volume":"9","author":"He","year":"2023","journal-title":"Cell Discov."},{"key":"10.1016\/j.cca.2026.121285_bb0080","series-title":"Hepatocellular Carcinoma: Diagnosis and Treatment","first-page":"287","article-title":"Metabolic Disease and Hepatocellular Carcinoma","author":"Van Thiel","year":"2016"},{"key":"10.1016\/j.cca.2026.121285_bb0085","series-title":"The Liver in Systemic Disease, an Issue of Clinics in Liver Disease: The Liver in Systemic Disease, An Issue of Clinics in Liver Disease, E-Book","author":"Jacobson","year":"2025"},{"issue":"1","key":"10.1016\/j.cca.2026.121285_bb0090","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s12026-023-09421-0","article-title":"Diverse functions of myeloid-derived suppressor cells in autoimmune diseases","volume":"72","author":"Xiong","year":"2024","journal-title":"Immunol. Res."},{"key":"10.1016\/j.cca.2026.121285_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1295257","article-title":"Tumor-associated macrophages: an effective player of the tumor microenvironment","volume":"14","author":"Basak","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2026.121285_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1472430","article-title":"Tumor-associated macrophages and CD8+ T cells: dual players in the pathogenesis of HBV-related HCC","volume":"15","author":"Khan","year":"2024","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.cca.2026.121285_bb0105","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s44222-024-00259-1","article-title":"Engineering circular RNA medicines","volume":"3","author":"Cao","year":"2025","journal-title":"Nature Reviews Bioengineering"},{"issue":"8","key":"10.1016\/j.cca.2026.121285_bb0110","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.7150\/thno.42174","article-title":"Circular RNA-protein interactions: functions, mechanisms, and identification","volume":"10","author":"Huang","year":"2020","journal-title":"Theranostics"},{"issue":"12","key":"10.1016\/j.cca.2026.121285_bb0115","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.7150\/ijbs.22531","article-title":"Circular RNAs: a novel type of non-coding RNA and their potential implications in antiviral immunity","volume":"13","author":"Wang","year":"2017","journal-title":"Int. J. Biol. Sci."},{"issue":"16","key":"10.1016\/j.cca.2026.121285_bb0120","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.3390\/ijms20163926","article-title":"Circular RNAs: biogenesis, mechanism, and function in human cancers","volume":"20","author":"Zhao","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.cca.2026.121285_bb0125","doi-asserted-by":"crossref","first-page":"726","DOI":"10.3390\/ijms26020726","article-title":"Circular RNA formation and degradation are not directed by universal pathways","volume":"26","author":"Srinivasan","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.cca.2026.121285_bb0130","article-title":"Emerging roles and context of circular RNAs","volume":"8","author":"Panda","year":"2017","journal-title":"Wiley Interdisciplinary Reviews: RNA"},{"issue":"1","key":"10.1016\/j.cca.2026.121285_bb0135","first-page":"1","article-title":"Molecular basis of backsplicing regulation and its application to manipulate circRNA levels","volume":"22","author":"Wang","year":"2025","journal-title":"RNA Biol."},{"issue":"8","key":"10.1016\/j.cca.2026.121285_bb0140","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.3390\/biomedicines10081865","article-title":"Internal ribosome entry site (IRES)-mediated translation and its potential for novel mRNA-based therapy development","volume":"10","author":"Marques","year":"2022","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.cca.2026.121285_bb0145","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s13046-023-02816-9","article-title":"CircRNF10 triggers a positive feedback loop to facilitate progression of glioblastoma via redeploying the ferroptosis defense in GSCs","volume":"42","author":"Wang","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.cca.2026.121285_bb0150","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/s10020-025-01347-7","article-title":"YULINK deficiency promotes cell death under glucose restriction in HCC cells in association with GLUT1-mediated glycolysis","volume":"31","author":"Wu","year":"2025","journal-title":"Mol. Med."},{"issue":"3","key":"10.1016\/j.cca.2026.121285_bb0155","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/ijc.70091","article-title":"Targeting aerobic glycolysis combats tyrosine kinase inhibitor resistance of hepatocellular carcinoma","volume":"158","author":"Zhao","year":"2026","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.cca.2026.121285_bb0160","article-title":"Prognostic value of LDH and \u03b1-HBDH dynamic levels for 1-year overall survival and progression-free survival in patients with extensive-stage small-cell lung cancer treated with chemoimmunotherapy","volume":"15","author":"Li","year":"2026","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.cca.2026.121285_bb0165","doi-asserted-by":"crossref","first-page":"610","DOI":"10.3390\/ijms26020610","article-title":"The pentose phosphate pathway: from mechanisms to implications for gastrointestinal cancers","volume":"26","author":"Qiao","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.cca.2026.121285_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e25144","article-title":"Huachansu suppresses the growth of hepatocellular carcinoma cells by interfering with pentose phosphate pathway through down-regulation of G6PD enzyme activity and expression","volume":"10","author":"Wu","year":"2024","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.cca.2026.121285_bb0175","first-page":"1","article-title":"The role of NRF2 in stress-driven signaling and metabolic reprogramming in cancer","volume":"7","author":"Pourteimoor","year":"2026","journal-title":"Yeni Y\u00fczy\u0131l Journal of Medical Sciences"},{"issue":"1","key":"10.1016\/j.cca.2026.121285_bb0180","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40170-023-00311-5","article-title":"A feedback loop of PPP and PI3K\/AKT signal pathway drives regorafenib-resistance in HCC","volume":"11","author":"Yang","year":"2023","journal-title":"Cancer & Metabolism"},{"issue":"10","key":"10.1016\/j.cca.2026.121285_bb0185","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1089\/cbr.2019.3472","article-title":"Circular RNA circ_0091579 promotes hepatocellular carcinoma proliferation, migration, invasion, and glycolysis through miR-490-5p\/CASC3 axis","volume":"36","author":"Liu","year":"2021","journal-title":"Cancer Biotherapy and Radiopharmaceuticals"},{"issue":"10","key":"10.1016\/j.cca.2026.121285_bb0190","first-page":"708","article-title":"Circ_0004913 inhibits cell growth, metastasis, and glycolysis by absorbing miR-184 to regulate HAMP in hepatocellular carcinoma","volume":"38","author":"Wu","year":"2023","journal-title":"Cancer Biother. Radiopharm."},{"issue":"1","key":"10.1016\/j.cca.2026.121285_bb0195","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70577","article-title":"N6-Methyladenosine modification of circIST1 promotes hypoxia-inducible factor \u03b1-mediated glycolysis and progression in hepatocellular carcinoma","volume":"7","author":"Zhan","year":"2026","journal-title":"MedComm"},{"issue":"1","key":"10.1016\/j.cca.2026.121285_bb0200","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40164-023-00378-2","article-title":"Hypoxia-associated circPRDM4 promotes immune escape via HIF-1\u03b1 regulation of PD-L1 in hepatocellular carcinoma","volume":"12","author":"Chen","year":"2023","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.cca.2026.121285_bb0205","article-title":"Myeloid-derived suppressor cells and regulatory T cells in colorectal cancer: a synergistic immunosuppressive axis and emerging therapeutic opportunities","volume":"17","author":"Zhang","year":"2026","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2026.121285_bb0210","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.2147\/CMAR.S537930","article-title":"Angiogenesis and immunosuppressive niche in hepatocellular carcinoma: reshaping vascular-immune Axis to potentiate antiPD-1\/PD-L1 therapy","author":"Li","year":"2025","journal-title":"Cancer Management and Research"},{"issue":"2","key":"10.1016\/j.cca.2026.121285_bb0215","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41577-025-01221-x","article-title":"Regulators of CD8+ T cell exhaustion","volume":"26","author":"Sun","year":"2026","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.cca.2026.121285_bb0220","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/med.21727","article-title":"Reinvigorating exhausted CD8+ cytotoxic T lymphocytes in the tumor microenvironment and current strategies in cancer immunotherapy","volume":"41","author":"Hossain","year":"2021","journal-title":"Med. Res. Rev."},{"issue":"3","key":"10.1016\/j.cca.2026.121285_bb0225","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.ymthe.2022.01.022","article-title":"Exosome-derived circTRPS1 promotes malignant phenotype and CD8+ T cell exhaustion in bladder cancer microenvironments","volume":"30","author":"Yang","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.cca.2026.121285_bb0230","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-026-02708-4","article-title":"Circular RNAs in tumor biology and immunology: molecular mechanisms and therapeutic implications","author":"Jiang","year":"2026","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.cca.2026.121285_bb0235","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41419-023-05647-w","article-title":"Regulation of the tumor immune microenvironment by cancer-derived circular RNAs","volume":"14","author":"Guan","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cca.2026.121285_bb0240","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1692547","article-title":"CD2 targeted nanoparticles containing IL-2 mimic fetal-maternal tolerance of pregnancy by inducing synergistic TGF-\u03b2-producing NK cells and Tregs","volume":"16","author":"Horwitz","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2026.121285_bb0245","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.819790","article-title":"Elevated levels of soluble CTLA-4, PD-1, PD-L1, LAG-3 and TIM-3 and systemic inflammatory stress as potential contributors to immune suppression and generalized tumorigenesis in a cohort of south African xeroderma pigmentosum patients","volume":"12","author":"Kgokolo","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.cca.2026.121285_bb0250","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12943-024-02224-3","article-title":"CircTTC13 promotes sorafenib resistance in hepatocellular carcinoma through the inhibition of ferroptosis by targeting the miR-513a-5p\/SLC7A11 axis","volume":"24","author":"Zhang","year":"2025","journal-title":"Mol. Cancer"},{"issue":"12","key":"10.1016\/j.cca.2026.121285_bb0255","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70488","article-title":"circRNA-SORE\/UBQLN1\/GPX4 mediates the Acquisition of Sorafenib Resistance in hepatocellular carcinoma through inhibition of ferroptosis","volume":"6","author":"Ji","year":"2025","journal-title":"MedComm"},{"issue":"10","key":"10.1016\/j.cca.2026.121285_bb0260","doi-asserted-by":"crossref","first-page":"792","DOI":"10.2174\/1568009623666230418121130","article-title":"The role of oxidative stress in the development and therapeutic intervention of hepatocellular carcinoma","volume":"23","author":"Liu","year":"2023","journal-title":"Curr. Cancer Drug Targets"},{"issue":"3","key":"10.1016\/j.cca.2026.121285_bb0265","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s12035-023-03646-8","article-title":"Oxytosis\/ferroptosis in neurodegeneration: the underlying role of master regulator glutathione peroxidase 4 (GPX4)","volume":"61","author":"Dar","year":"2024","journal-title":"Mol. Neurobiol."},{"issue":"11","key":"10.1016\/j.cca.2026.121285_bb0270","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1002\/cbin.11444","article-title":"CircIL4R facilitates the tumorigenesis and inhibits ferroptosis in hepatocellular carcinoma by regulating the miR-541-3p\/GPX4 axis","volume":"44","author":"Xu","year":"2020","journal-title":"Cell Biol. Int."},{"issue":"2","key":"10.1016\/j.cca.2026.121285_bb0275","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41416-022-01998-x","article-title":"Ferroptosis in hepatocellular carcinoma: mechanisms and targeted therapy","volume":"128","author":"Ajoolabady","year":"2023","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.cca.2026.121285_bb0280","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3390\/cancers17030392","article-title":"Hepatic iron overload and hepatocellular carcinoma: new insights into pathophysiological mechanisms and therapeutic approaches","volume":"17","author":"Chatzikalil","year":"2025","journal-title":"Cancers"},{"issue":"13","key":"10.1016\/j.cca.2026.121285_bb0285","first-page":"607656","article-title":"Post-translational modification networks in ferroptosis: orchestrating defense, drug resistance, and therapeutic opportunities in hepatocellular carcinoma","volume":"21","author":"Chen","year":"2026","journal-title":"J. Hepatocell. Carcinoma"},{"issue":"1","key":"10.1016\/j.cca.2026.121285_bb0290","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13046-023-02925-5","article-title":"Modulating ferroptosis sensitivity: environmental and cellular targets within the tumor microenvironment","volume":"43","author":"Hua","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.cca.2026.121285_bb0295","article-title":"System xc\u2212\/GSH\/GPX4 axis: an important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy","volume":"13","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.cca.2026.121285_bb0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0302050","article-title":"The efficacy of ferroptosis-inducing compounds IKE and RSL3 correlates with the expression of ferroptotic pathway regulators CD71 and SLC7A11 in biliary tract cancer cells","volume":"19","author":"Bekric","year":"2024","journal-title":"PloS One"},{"issue":"8","key":"10.1016\/j.cca.2026.121285_bb0305","article-title":"CircRNA hsa_circ_0110102 inhibited macrophage activation and hepatocellular carcinoma progression via miR-580-5p\/PPAR\u03b1\/CCL2 pathway","volume":"13","author":"Wang","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"10.1016\/j.cca.2026.121285_bb0310","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12943-023-01759-1","article-title":"Exosome-derived circCCAR1 promotes CD8+ T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma","volume":"22","author":"Hu","year":"2023","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.cca.2026.121285_bb0315","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/hep.30671","article-title":"Circular RNA MAT2B promotes glycolysis and malignancy of hepatocellular carcinoma through the miR-338-3p\/PKM2 axis under hypoxic stress","volume":"70","author":"Li","year":"2019","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cca.2026.121285_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e17120","article-title":"Circular RNA circBNC2 facilitates glycolysis and stemness of hepatocellular carcinoma through the miR-217\/high mobility group AT-hook 2 (HMGA2) axis","volume":"9","author":"Feng","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.cca.2026.121285_bb0325","doi-asserted-by":"crossref","first-page":"12945","DOI":"10.2147\/CMAR.S280478","article-title":"CircPVT1 regulates cell proliferation, apoptosis and glycolysis in hepatocellular carcinoma via miR-377\/TRIM23 axis","author":"Bu","year":"2020","journal-title":"Cancer Manag. Res."},{"issue":"3","key":"10.1016\/j.cca.2026.121285_bb0330","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.aohep.2020.01.002","article-title":"Circ-PRMT5 enhances the proliferation, migration and glycolysis of hepatoma cells by targeting miR-188-5p\/HK2 axis","volume":"19","author":"Ding","year":"2020","journal-title":"Ann. Hepatol."},{"issue":"12","key":"10.1016\/j.cca.2026.121285_bb0335","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23991","article-title":"Hsa_circ_0001806 promotes glycolysis and cell progression in hepatocellular carcinoma through miR-125b\/HK2","volume":"35","author":"Chen","year":"2021","journal-title":"J. Clin. Lab. Anal."},{"issue":"3","key":"10.1016\/j.cca.2026.121285_bb0340","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1080\/21655979.2022.2031398","article-title":"The novel circular RNA HIPK3 accelerates the proliferation and invasion of hepatocellular carcinoma cells by sponging the micro RNA-124 or micro RNA-506\/pyruvate dehydrogenase kinase 2 axis","volume":"13","author":"Yu","year":"2022","journal-title":"Bioengineered"},{"issue":"12","key":"10.1016\/j.cca.2026.121285_bb0345","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1007\/s10620-020-06805-2","article-title":"Circular RNA circZFR promotes hepatocellular carcinoma progression by regulating miR-375\/HMGA2 axis","volume":"66","author":"Xu","year":"2021","journal-title":"Dig. Dis. Sci."},{"issue":"11","key":"10.1016\/j.cca.2026.121285_bb0350","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1007\/s12094-021-02627-4","article-title":"Circular RNA hsa_circ_0091579 facilitates the Warburg effect and malignancy of hepatocellular carcinoma cells via the miR-624\/H3F3B axis","volume":"23","author":"Chen","year":"2021","journal-title":"Clin. Transl. Oncol."},{"issue":"6","key":"10.1016\/j.cca.2026.121285_bb0355","first-page":"6076","article-title":"Circular RNA circUBE2D2 functions as an oncogenic factor in hepatocellular carcinoma sorafenib resistance and glycolysis","volume":"13","author":"Huang","year":"2021","journal-title":"Am. J. Transl. Res."},{"issue":"1","key":"10.1016\/j.cca.2026.121285_bb0360","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13046-023-02624-1","article-title":"CircFOXK2 promotes hepatocellular carcinoma progression and leads to a poor clinical prognosis via regulating the Warburg effect","volume":"42","author":"Zheng","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.cca.2026.121285_bb0365","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1089\/cbr.2020.3564","article-title":"Exosomal circFBLIM1 promotes hepatocellular carcinoma progression and glycolysis by regulating the miR-338\/LRP6 axis","volume":"38","author":"Lai","year":"2023","journal-title":"Cancer Biotherapy and Radiopharmaceuticals"},{"key":"10.1016\/j.cca.2026.121285_bb0370","doi-asserted-by":"crossref","first-page":"7739","DOI":"10.2147\/CMAR.S259424","article-title":"Exosomal Circ-ZNF652 promotes cell proliferation, migration, invasion and glycolysis in hepatocellular carcinoma via miR-29a-3p\/GUCD1 axis","author":"Li","year":"2020","journal-title":"Cancer Management and Research"},{"issue":"1","key":"10.1016\/j.cca.2026.121285_bb0375","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13765-022-00723-9","article-title":"circTUBGCP5 promotes liver cancer progression and glycolysis by up-regulating the expression of ACSL4","volume":"65","author":"Dai","year":"2022","journal-title":"Appl. Biol. Chem."},{"key":"10.1016\/j.cca.2026.121285_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.111660","article-title":"IGF2BP1\/AIFM2 axis regulates ferroptosis and glycolysis to drive hepatocellular carcinoma progression","volume":"130","author":"Peng","year":"2025","journal-title":"Cell. Signal."},{"issue":"4","key":"10.1016\/j.cca.2026.121285_bb0385","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s10142-023-01256-0","article-title":"Hypoxia-induced circRTN4IP1 promotes progression and glycolysis of hepatocellular carcinoma cells","volume":"23","author":"Yang","year":"2023","journal-title":"Funct. Integr. Genomics"},{"key":"10.1016\/j.cca.2026.121285_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216872","article-title":"Tumor-associated macrophage-induced circMRCK\u03b1 encodes a peptide to promote glycolysis and progression in hepatocellular carcinoma","volume":"591","author":"Yu","year":"2024","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.cca.2026.121285_bb0395","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/s41419-024-06743-1","article-title":"Energy stress-induced circDDX21 promotes glycolysis and facilitates hepatocellular carcinogenesis","volume":"15","author":"Luo","year":"2024","journal-title":"Cell Death Dis."},{"issue":"19","key":"10.1016\/j.cca.2026.121285_bb0400","doi-asserted-by":"crossref","first-page":"9725","DOI":"10.3390\/ijms26199725","article-title":"Circular RNAs in cardiovascular physiopathology: from molecular mechanisms to therapeutic opportunities","volume":"26","author":"Capirossi","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cca.2026.121285_bb0405","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41392-021-00569-5","article-title":"Targeting circular RNAs as a therapeutic approach: current strategies and challenges","volume":"6","author":"He","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.cca.2026.121285_bb0410","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s12672-025-03335-z","article-title":"WGCNA and single-cell analysis reveal ferroptosis-related gene signatures for hepatocellular carcinoma prognosis and therapy","volume":"16","author":"Peng","year":"2025","journal-title":"Discover Oncology"},{"issue":"1","key":"10.1016\/j.cca.2026.121285_bb0415","article-title":"Integrating single-cell RNA sequencing, WGCNA, and machine learning to identify key biomarkers in hepatocellular carcinoma","volume":"15","author":"Wang","year":"2025","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.cca.2026.121285_bb0420","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1158\/0008-5472.CAN-21-1259","article-title":"CircRPN2 inhibits aerobic glycolysis and metastasis in hepatocellular carcinoma","volume":"82","author":"Li","year":"2022","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.cca.2026.121285_bb0425","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3892\/mmr.2021.12103","article-title":"Circ-PRKCI targets miR-1294 and miR-186-5p by downregulating FOXK1 expression to suppress glycolysis in hepatocellular carcinoma","volume":"23","author":"Chen","year":"2021","journal-title":"Mol. Med. Rep."},{"issue":"6","key":"10.1016\/j.cca.2026.121285_bb0430","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3892\/ol.2020.12251","article-title":"Hypoxia-induced circular RNA hsa_circ_0008450 accelerates hepatocellular cancer progression via the miR-431\/AKAP1 axis","volume":"20","author":"Du","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.cca.2026.121285_bb0435","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ncrna.2025.11.006","article-title":"The regulatory role of circGDI2 in hepatocellular carcinoma proliferation and glycolysis with the involvement of m6A modification","volume":"17","author":"Chen","year":"2026","journal-title":"Noncoding RNA Res."},{"issue":"1","key":"10.1016\/j.cca.2026.121285_bb0440","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41419-025-07414-5","article-title":"The RNA M5C methyltransferase NSUN2 promotes progression of hepatocellular carcinoma by enhancing PKM2-mediated glycolysis","volume":"16","author":"Qi","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cca.2026.121285_bb0445","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.omto.2022.02.021","article-title":"CircRHBDD1 augments metabolic rewiring and restricts immunotherapy efficacy via m6A modification in hepatocellular carcinoma","volume":"24","author":"Cai","year":"2022","journal-title":"Molecular Therapy-Oncolytics"},{"issue":"1","key":"10.1016\/j.cca.2026.121285_bb0450","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s11658-022-00406-9","article-title":"Exosomal miR-628-5p from M1 polarized macrophages hinders m6A modification of circFUT8 to suppress hepatocellular carcinoma progression","volume":"27","author":"Wang","year":"2022","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"7","key":"10.1016\/j.cca.2026.121285_bb0455","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.dld.2022.12.005","article-title":"WTAP-mediated m6A modification on circCMTM3 inhibits hepatocellular carcinoma ferroptosis by recruiting IGF2BP1 to increase PARK7 stability","volume":"55","author":"Chen","year":"2023","journal-title":"Dig. Liver Dis."},{"issue":"45","key":"10.1016\/j.cca.2026.121285_bb0460","article-title":"Lactate metabolic reprogramming mediated by CircRNA-LDHA complex facilitates innate immune evasion of liver Cancer","volume":"12","author":"Shen","year":"2025","journal-title":"Adv Sci (Weinh)"},{"issue":"2","key":"10.1016\/j.cca.2026.121285_bb0465","article-title":"A mammalian conserved circular RNA CircLARP1B regulates hepatocellular carcinoma metastasis and lipid metabolism","volume":"11","author":"Li","year":"2024","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"10.1016\/j.cca.2026.121285_bb0470","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41419-022-05540-y","article-title":"CircRNA MBOAT2 promotes intrahepatic cholangiocarcinoma progression and lipid metabolism reprogramming by stabilizing PTBP1 to facilitate FASN mRNA cytoplasmic export","volume":"14","author":"Yu","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cca.2026.121285_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.218188","article-title":"Hypoxia-related CircARSB modulates lipid metabolism and innate immune crosstalk to influence immune checkpoint inhibitor response in hepatocellular carcinoma","volume":"639","author":"Song","year":"2026","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.cca.2026.121285_bb0480","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41392-020-0105-2","article-title":"The circFASN\/miR-33a pathway participates in tacrolimus-induced dysregulation of hepatic triglyceride homeostasis","volume":"5","author":"Zhang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.cca.2026.121285_bb0485","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s12951-024-02582-6","article-title":"Exosome-derived circUPF2 enhances resistance to targeted therapy by redeploying ferroptosis sensitivity in hepatocellular carcinoma","volume":"22","author":"Dong","year":"2024","journal-title":"J. Nanobiotechnol."},{"issue":"04","key":"10.1016\/j.cca.2026.121285_bb0490","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.cpt.2024.11.003","article-title":"Circular RNA vaccines: pioneering the next-gen cancer immunotherapy","volume":"3","author":"Das","year":"2025","journal-title":"Cancer Pathog. Ther."},{"issue":"8","key":"10.1016\/j.cca.2026.121285_bb0495","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/exd.14227","article-title":"Characterization of circular RNA transcriptomes in psoriasis and atopic dermatitis reveals disease-specific expression profiles","volume":"30","author":"Moldovan","year":"2021","journal-title":"Exp. Dermatol."},{"issue":"1","key":"10.1016\/j.cca.2026.121285_bb0500","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13073-024-01400-w","article-title":"Circular RNA landscape in extracellular vesicles from human biofluids","volume":"16","author":"Zhao","year":"2024","journal-title":"Genome Med."},{"issue":"12","key":"10.1016\/j.cca.2026.121285_bb0505","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24003","article-title":"circCORO1C promotes the proliferation and metastasis of hepatocellular carcinoma by enhancing the expression of PD-L1 through NF-\u03baB pathway","volume":"35","author":"Wu","year":"2021","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.cca.2026.121285_bb0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.143246","article-title":"Circular RNA CDYL facilitates hepatocellular carcinoma stemness and PD-L1+ exosomes-mediated immunotherapy resistance via stabilizing hornerin protein by blocking synoviolin 1-mediated ubiquitination","volume":"310","author":"Fu","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"6","key":"10.1016\/j.cca.2026.121285_bb0515","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1111\/cas.15365","article-title":"Exosomal circGSE1 promotes immune escape of hepatocellular carcinoma by inducing the expansion of regulatory T cells","volume":"113","author":"Huang","year":"2022","journal-title":"Cancer Sci."},{"issue":"2","key":"10.1016\/j.cca.2026.121285_bb0520","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s10528-022-10273-w","article-title":"CircSOD2 contributes to tumor progression, immune evasion and anti-PD-1 resistance in hepatocellular carcinoma by targeting miR-497-5p\/ANXA11 axis","volume":"61","author":"Ye","year":"2023","journal-title":"Biochem. Genet."},{"key":"10.1016\/j.cca.2026.121285_bb0525","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.2147\/IJN.S461289","article-title":"Synergistic immunoregulation: harnessing CircRNAs and PiRNAs to amplify PD-1\/PD-L1 inhibition therapy","volume":"19","author":"Han","year":"2024","journal-title":"Int. J. Nanomedicine"},{"issue":"1","key":"10.1016\/j.cca.2026.121285_bb0530","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12935-021-01902-2","article-title":"Circular RNA hsa_circ_0003288 induces EMT and invasion by regulating hsa_circ_0003288\/miR-145\/PD-L1 axis in hepatocellular carcinoma","volume":"21","author":"Xu","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"6","key":"10.1016\/j.cca.2026.121285_bb0535","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1002\/tox.24188","article-title":"Circ_0027791 contributes to the growth and immune evasion of hepatocellular carcinoma via the miR-496\/programmed cell death ligand 1 axis in an m6A-dependent manner","volume":"39","author":"Yu","year":"2024","journal-title":"Environ. Toxicol."},{"issue":"12","key":"10.1016\/j.cca.2026.121285_bb0540","first-page":"1185","article-title":"Hsa_circ_0048674 facilitates hepatocellular carcinoma progression and natural killer cell exhaustion depending on the regulation of miR-223-3p\/PDL1","volume":"37","author":"Li","year":"2022","journal-title":"Histol. Histopathol."},{"issue":"15","key":"10.1016\/j.cca.2026.121285_bb0545","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1097\/CM9.0000000000004120","article-title":"Circulating circRNAs at the frontier of cancer detection, prognosis, and therapy","volume":"139","author":"Zhang","year":"2026","journal-title":"Chin Med J (Engl)"},{"issue":"3","key":"10.1016\/j.cca.2026.121285_bb0550","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41416-021-01672-8","article-title":"Non-coding RNAs as liquid biopsy biomarkers in cancer","volume":"126","author":"Toden","year":"2022","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.cca.2026.121285_bb0555","doi-asserted-by":"crossref","first-page":"87","DOI":"10.7150\/thno.64096","article-title":"The potential role of exosomal circRNAs in the tumor microenvironment: insights into cancer diagnosis and therapy","volume":"12","author":"Li","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.cca.2026.121285_bb0560","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.2147\/IJN.S284560","article-title":"Downregulation of hsa_circ_0074854 suppresses the migration and invasion in hepatocellular carcinoma via interacting with HuR and via suppressing exosomes-mediated macrophage M2 polarization","author":"Wang","year":"2021","journal-title":"Int. J. Nanomedicine"},{"issue":"1","key":"10.1016\/j.cca.2026.121285_bb0565","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41419-021-04345-9","article-title":"Exosomal hsa_circ_0004658 derived from RBPJ overexpressed-macrophages inhibits hepatocellular carcinoma progression via miR-499b-5p\/JAM3","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.cca.2026.121285_bb0570","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/cac2.12574","article-title":"Exposure of benzo [a] pyrene induces HCC exosome-circular RNA to activate lung fibroblasts and trigger organotropic metastasis","volume":"44","author":"Mu","year":"2024","journal-title":"Cancer Commun."},{"issue":"1","key":"10.1016\/j.cca.2026.121285_bb0575","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1186\/s12885-022-10367-z","article-title":"Exosome-transmitted circ_002136 promotes hepatocellular carcinoma progression by miR-19a-3p\/RAB1A pathway","volume":"22","author":"Yuan","year":"2022","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.cca.2026.121285_bb0580","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/cas.15238","article-title":"hsa_circ_0003410 promotes hepatocellular carcinoma progression by increasing the ratio of M2\/M1 macrophages through the miR-139-3p\/CCL5 axis","volume":"113","author":"Cao","year":"2022","journal-title":"Cancer Sci."},{"issue":"4","key":"10.1016\/j.cca.2026.121285_bb0585","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/jvh.13917","article-title":"Hsa_circ_0010882 facilitates hepatocellular carcinoma progression by modulating M1\/M2 macrophage polarization","volume":"31","author":"Yang","year":"2024","journal-title":"J. Viral Hepat."},{"issue":"2","key":"10.1016\/j.cca.2026.121285_bb0590","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41577-022-00732-1","article-title":"Roles of natural killer cells in immunity to cancer, and applications to immunotherapy","volume":"23","author":"Wolf","year":"2023","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.cca.2026.121285_bb0595","first-page":"388","article-title":"circRNA of AR-suppressed PABPC1 91 bp enhances the cytotoxicity of natural killer cells against hepatocellular carcinoma via upregulating UL16 binding protein 1","volume":"17","author":"Ma","year":"2019","journal-title":"Oncol. Lett."},{"issue":"3","key":"10.1016\/j.cca.2026.121285_bb0600","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/HEP.0000000000001605","article-title":"GPC3-based circular RNA vaccine suppresses hepatocellular carcinoma progression by activating adaptive immune responses","volume":"84","author":"Jiang","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.cca.2026.121285_bb0605","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1609165","article-title":"Utilization of artificial circular RNAs as miRNA sponges and anti-PD-1 scFv expression platforms to suppress hepatocellular carcinoma progression","volume":"16","author":"Lai","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2026.121285_bb0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217470","article-title":"CircCCNY enhances lenvatinib sensitivity and suppresses immune evasion in hepatocellular carcinoma by serving as a scaffold for SMURF1 mediated HSP60 degradation","volume":"612","author":"Yang","year":"2025","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.cca.2026.121285_bb0615","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3390\/vaccines13060563","article-title":"Rational design and immunological mechanisms of circular RNA-based vaccines: emerging Frontiers in combating pathogen infection","volume":"13","author":"Zhang","year":"2025","journal-title":"Vaccines"},{"key":"10.1016\/j.cca.2026.121285_bb0620","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1723383","article-title":"From immune suppression to immunotherapy sensitization: the dual roles of circRNAs in cancer progression","volume":"16","author":"Dai","year":"2025","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.cca.2026.121285_bb0625","doi-asserted-by":"crossref","first-page":"675","DOI":"10.21037\/atm-21-997","article-title":"Ferroptosis is involved in the progression of hepatocellular carcinoma through the circ0097009\/miR-1261\/SLC7A11 axis","volume":"9","author":"Lyu","year":"2021","journal-title":"Annals of Translational Medicine"},{"key":"10.1016\/j.cca.2026.121285_bb0630","doi-asserted-by":"crossref","DOI":"10.25259\/JKSUS_38_2025","article-title":"Circular RNA circPRKCA represses ferroptosis of hepatocellular carcinoma by promoting SLC7A11","volume":"37","author":"Zhou","year":"2025","journal-title":"J. King Saud Univ. Sci."},{"issue":"1","key":"10.1016\/j.cca.2026.121285_bb0635","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12943-024-02030-x","article-title":"CircPIAS1 promotes hepatocellular carcinoma progression by inhibiting ferroptosis via the miR-455-3p\/NUPR1\/FTH1 axis","volume":"23","author":"Zhang","year":"2024","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.cca.2026.121285_bb0640","doi-asserted-by":"crossref","DOI":"10.1080\/15592294.2023.2192438","article-title":"Suppressing circIDE\/miR-19b-3p\/RBMS1 axis exhibits promoting-tumour activity through upregulating GPX4 to diminish ferroptosis in hepatocellular carcinoma","volume":"18","author":"Zhai","year":"2023","journal-title":"Epigenetics"},{"issue":"1","key":"10.1016\/j.cca.2026.121285_bb0645","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41420-020-00306-x","article-title":"Circular RNA cIARS regulates ferroptosis in HCC cells through interacting with RNA binding protein ALKBH5","volume":"6","author":"Liu","year":"2020","journal-title":"Cell death discovery"},{"issue":"1","key":"10.1016\/j.cca.2026.121285_bb0650","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10528-023-10417-6","article-title":"Circular RNA 0016142 knockdown induces ferroptosis in hepatocellular carcinoma cells via modulation of the microRNA-188-3p\/glutathione peroxidase 4 axis","volume":"62","author":"Liu","year":"2024","journal-title":"Biochem. Genet."},{"issue":"17","key":"10.1016\/j.cca.2026.121285_bb0655","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1080\/15384101.2023.2249302","article-title":"circFAM134B is a key factor regulating reticulophagy-mediated ferroptosis in hepatocellular carcinoma","volume":"22","author":"Bi","year":"2023","journal-title":"Cell Cycle"},{"issue":"23","key":"10.1016\/j.cca.2026.121285_bb0660","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16233944","article-title":"Resistance to tyrosine kinase inhibitors in hepatocellular carcinoma (HCC): clinical implications and potential strategies to overcome the resistance","volume":"16","author":"Gawi Ermi","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.cca.2026.121285_bb0665","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2147\/ITT.S463556","article-title":"Circ_0001944 targets the mir-1292-5p\/fbln2 axis to facilitate sorafenib resistance in hepatocellular carcinoma by impeding ferroptosis","author":"Jing","year":"2024","journal-title":"ImmunoTargets and Therapy"},{"key":"10.1016\/j.cca.2026.121285_bb0670","series-title":"From (Epi) genetics-to-Precision (E2P) Non-protein Coding RNAs (ncRNAs) a Step-toward Precision Medicine","first-page":"237","article-title":"Noncoding RNAs: A Novel Frontier in Liver Cancer Research and Therapy: Implications for Precision Oncology","author":"Sallam","year":"2026"},{"issue":"1","key":"10.1016\/j.cca.2026.121285_bb0675","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s12672-025-01743-9","article-title":"Circular RNAs in cancer: roles, mechanisms, and therapeutic potential across colorectal, gastric, liver, and lung carcinomas","volume":"16","author":"Malviya","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.cca.2026.121285_bb0680","article-title":"Comprehensive circRNA profiling of platelets and exosomes identifies hsa_circ_0061274 as a novel biomarker for lung adenocarcinoma","volume":"17","author":"Zhang","year":"2026","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cca.2026.121285_bb0685","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3233\/CBM-150552","article-title":"Hsa_circ_0001649: a circular RNA and potential novel biomarker for hepatocellular carcinoma","volume":"16","author":"Qin","year":"2016","journal-title":"Cancer Biomark."},{"issue":"22","key":"10.1016\/j.cca.2026.121285_bb0690","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003811","article-title":"Comprehensive circular RNA profiling reveals that hsa_circ_0005075, a new circular RNA biomarker, is involved in hepatocellular crcinoma development","volume":"95","author":"Shang","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.cca.2026.121285_bb0695","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cca.2019.02.001","article-title":"Using circular RNA SMARCA5 as a potential novel biomarker for hepatocellular carcinoma","volume":"492","author":"Li","year":"2019","journal-title":"Clin. Chim. Acta"},{"issue":"2","key":"10.1016\/j.cca.2026.121285_bb0700","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1080\/21655979.2021.2006952","article-title":"Circular RNA hsa_circ_0006091 as a novel biomarker for hepatocellular carcinoma","volume":"13","author":"Zhang","year":"2022","journal-title":"Bioengineered"},{"issue":"10","key":"10.1016\/j.cca.2026.121285_bb0705","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.3390\/ijms26104842","article-title":"Preliminary evaluation of plasma circ_0009910, circ_0027478, and miR-1236-3p as diagnostic and prognostic biomarkers in hepatocellular carcinoma","volume":"26","author":"Awed","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.cca.2026.121285_bb0710","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3892\/ijo.2025.5839","article-title":"Exosomal circRNAs in hepatocellular carcinoma: implications for the development and therapeutic resistance of hepatocellular carcinoma","volume":"68","author":"Liu","year":"2025","journal-title":"Int. J. Oncol."},{"issue":"8","key":"10.1016\/j.cca.2026.121285_bb0715","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3390\/cancers10080258","article-title":"Circular RNAs: characteristics, function and clinical significance in hepatocellular carcinoma","volume":"10","author":"Wang","year":"2018","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.cca.2026.121285_bb0720","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1002\/ijc.32647","article-title":"Plasma circular RNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma: a large-scale, multicenter study","volume":"146","author":"Yu","year":"2020","journal-title":"Int. J. Cancer"},{"issue":"12","key":"10.1016\/j.cca.2026.121285_bb0725","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.70282","article-title":"Identification of serum-derived CricRNA diagnostic panel and revealing their regulatory mechanisms in HCV-HCC: a cross-sectional study","volume":"7","author":"Ishaq","year":"2024","journal-title":"Health Science Reports"},{"issue":"1","key":"10.1016\/j.cca.2026.121285_bb0730","article-title":"Circular noncoding RNA hsa_circ_0005986 as a prognostic biomarker for hepatocellular carcinoma","volume":"11","author":"Kim","year":"2021","journal-title":"Sci. Rep."},{"issue":"2019","key":"10.1016\/j.cca.2026.121285_bb0735","article-title":"Systematic review and meta-analysis of the utility of circular RNAs as biomarkers of hepatocellular carcinoma","volume":"1","author":"Hao","year":"2019","journal-title":"Can. J. Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.cca.2026.121285_bb0740","doi-asserted-by":"crossref","first-page":"7711","DOI":"10.1002\/jcb.28045","article-title":"circRNAs (hsa_circ_00156, hsa_circ _000224, and hsa_circ _000520) are novel potential biomarkers in hepatocellular carcinoma","volume":"120","author":"Matboli","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.cca.2026.121285_bb0745","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s12935-020-01302-y","article-title":"Serum-derived three-circRNA signature as a diagnostic biomarker for hepatocellular carcinoma","volume":"20","author":"Sun","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.cca.2026.121285_bb0750","article-title":"Integrative single-cell and spatial transcriptomics uncover ELK4-mediated mechanisms in NDUFAB1+ tumor cells driving gastric cancer progression, metabolic reprogramming, and immune evasion","volume":"16","author":"Sun","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2026.121285_bb0755","article-title":"Integrating in silico perturbation with multilayer omics to decode regulatory networks in cancer immunity: a new frontier in precision oncology","volume":"17","author":"Chen","year":"2026","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2026.121285_bb0760","first-page":"1","article-title":"Metabolic reprogramming of myeloid cells in cancer: from lactate\u2013NAMPT axis to AI-guided therapeutics","author":"Lee","year":"2026","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.cca.2026.121285_bb0765","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s12943-024-02131-7","article-title":"CircRNA and lncRNA-encoded peptide in diseases, an update review","volume":"23","author":"Yi","year":"2024","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.cca.2026.121285_bb0770","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41389-025-00587-w","article-title":"RNA m5C methylation in cancer: mechanisms and biological impact","volume":"14","author":"Guan","year":"2025","journal-title":"Oncogenesis"},{"key":"10.1016\/j.cca.2026.121285_bb0775","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.20123","article-title":"Establishment and evaluation of a circAdpgk-0001 knockdown method using CRISPR\u2013Cas13d RNA-targeting technology","volume":"13","author":"Huang","year":"2025","journal-title":"PeerJ"},{"issue":"8","key":"10.1016\/j.cca.2026.121285_bb0780","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.104066","article-title":"CircRNA knockdown based on antisense strategies","volume":"29","author":"Aquino-Jarquin","year":"2024","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.cca.2026.121285_bb0785","article-title":"Circular RNAs: roles in hepatocellular carcinoma immune regulation, implications in immunotherapy, and prospects for clinical translation","volume":"12","author":"Chen","year":"2025","journal-title":"Front. Mol. Biosci."},{"issue":"8","key":"10.1016\/j.cca.2026.121285_bb0790","doi-asserted-by":"crossref","DOI":"10.1002\/adtp.202500082","article-title":"RNA-based therapeutics: cutting-edge advances in clinical research","volume":"8","author":"Ferreira","year":"2025","journal-title":"Advanced Therapeutics"},{"issue":"1","key":"10.1016\/j.cca.2026.121285_bb0795","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12943-024-01969-1","article-title":"Correction: circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p\/snail\/DPP4 axis","volume":"23","author":"Huang","year":"2024","journal-title":"Mol. Cancer"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126004675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126004675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:27:39Z","timestamp":1792081659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898126004675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,2]]},"references-count":159,"alternative-id":["S0009898126004675"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2026.121285","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2027,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circular RNAs as diagnostic biomarkers and therapeutic regulators of metabolic reprogramming, immune escape and ferroptosis in hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2026.121285","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"121285"}}